Iradimed (IRMD) Free Cash Flow (2013 - 2026)

Iradimed (IRMD) has reported Free Cash Flow for 14 consecutive years, with $5.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 12.6% year-over-year to $5.8 million in Q2 2026; TTM through Jun 2026 was $25.1 million, a 76.79% increase from a year earlier, with the FY2025 full-year figure at $17.2 million, down 2.48% from the prior year.
• Free Cash Flow was $5.8 million for Q2 2026 at Iradimed, down from $7.9 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $7.9 million in Q1 2026 and troughed at -$1.7 million in Q1 2023.
• A 5-year average of $3.5 million and a median of $3.5 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 247.68% in 2023 and surged 1225.55% in 2026, its largest moves.
• Over 5 years, Free Cash Flow stood at $2.8 million in 2022, then climbed by 19.65% to $3.4 million in 2023, then declined by 5.45% to $3.2 million in 2024, then surged by 76.08% to $5.6 million in 2025, then climbed by 2.25% to $5.8 million in 2026.
• The last three Free Cash Flow figures came in at $5.8 million (Q2 2026), $7.9 million (Q1 2026), and $5.6 million (Q4 2025), per Business Quant data.